Real-time enrollment status for this acute promyelocytic leukemia (apl) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:41 AM UTC
| NCT Number | NCT07504458 |
| Recruiting Status | Recruiting |
| Condition | Acute Promyelocytic Leukemia (APL) |
| Phase | Clinical Trial |
| Target Enrollment | 150 participants |
| Active Locations | 8 sites in the US |
| Sponsor | Quetzal Therapeutics |
| Last Updated on CT.gov | July 10, 2026 (3 days ago) |
As of July 13, 2026: Clinical trial NCT07504458 is currently recruiting participants. This clinical trial study for acute promyelocytic leukemia (apl) is actively seeking new participants at 8 locations across the United States. The study is sponsored by Quetzal Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07504458 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07504458 was last updated 3 days ago (July 10, 2026). HelloStudys verifies this status automatically.